-
1
-
2
Figure S4 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Baskı/Yayın Bilgisi 2025Konular: -
3
Figure S2 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Baskı/Yayın Bilgisi 2025Konular: -
4
Figure S8 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Baskı/Yayın Bilgisi 2025Konular: -
5
Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Baskı/Yayın Bilgisi 2025Konular: -
6
Figure S7 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Baskı/Yayın Bilgisi 2025Konular: -
7
Figure S5 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Baskı/Yayın Bilgisi 2025Konular: -
8
Figure S3 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Baskı/Yayın Bilgisi 2025Konular: -
9
Figure S6 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
Baskı/Yayın Bilgisi 2025Konular: -
10
-
11
-
12
-
13
-
14
Supplementary Table S1 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Baskı/Yayın Bilgisi 2025Konular: -
15
Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Baskı/Yayın Bilgisi 2025Konular: -
16
Supplementary Table S3 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Baskı/Yayın Bilgisi 2025Konular: -
17
Supplementary Table S4 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Baskı/Yayın Bilgisi 2025Konular: -
18
Supplementary Table S5 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
Baskı/Yayın Bilgisi 2025Konular: -
19
Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
Baskı/Yayın Bilgisi 2025Konular: -
20
Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
Baskı/Yayın Bilgisi 2025Konular: